On Tuesday, Repligen Corp (NASDAQ: RGEN) opened higher 6.51% from the last session, before settling in for the closing price of $139.51. Price fluctuations for RGEN have ranged from $113.50 to $211.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 31.42% over the last five years. Company’s average yearly earnings per share was noted -15.20% at the time writing. With a float of $52.09 million, this company’s outstanding shares have now reached $55.77 million.
The firm has a total of 1783 workers. Let’s measure their productivity. In terms of profitability, gross margin is 41.15%, operating margin of 1.56%, and the pretax margin is 1.69%.
Repligen Corp (RGEN) Insider Activity
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Repligen Corp is 6.98%, while institutional ownership is 103.86%. The most recent insider transaction that took place on Sep 10 ’24, was worth 3,225,927. In this transaction Director of this company sold 22,191 shares at a rate of $145.37, taking the stock ownership to the 139,840 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Officer proposed sale 22,191 for $144.72, making the entire transaction worth $3,211,481.
Repligen Corp (RGEN) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 0.23 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.17) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.00% during the next five years compared to 15.08% growth over the previous five years of trading.
Repligen Corp (NASDAQ: RGEN) Trading Performance Indicators
Check out the current performance indicators for Repligen Corp (RGEN). In the past quarter, the stock posted a quick ratio of 5.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.82. Likewise, its price to free cash flow for the trailing twelve months is 69.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit 0.46 in the next quarter and is forecasted to reach 1.83 in one year’s time.
Technical Analysis of Repligen Corp (RGEN)
Analysing the last 5-days average volume posted by the [Repligen Corp, RGEN], we can find that recorded value of 0.69 million was better than the volume posted last year of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 49.03%. Additionally, its Average True Range was 6.16.
During the past 100 days, Repligen Corp’s (RGEN) raw stochastic average was set at 56.27%, which indicates a significant decrease from 71.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.99% in the past 14 days, which was lower than the 50.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $141.47, while its 200-day Moving Average is $158.11. Now, the first resistance to watch is $153.71. This is followed by the second major resistance level at $158.84. The third major resistance level sits at $163.19. If the price goes on to break the first support level at $144.23, it is likely to go to the next support level at $139.88. Should the price break the second support level, the third support level stands at $134.75.
Repligen Corp (NASDAQ: RGEN) Key Stats
There are currently 56,007K shares outstanding in the company with a market cap of 8.32 billion. Presently, the company’s annual sales total 638,760 K according to its annual income of 41,580 K. Last quarter, the company’s sales amounted to 154,070 K and its income totaled 3,320 K.
